Primoris Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Hold
264
0.17% 83
2025
Q4
$284K Hold
264
0.17% 93
2025
Q3
$201K Buy
264
+3
+1% +$2.23K 0.13% 101
2025
Q2
$203K Buy
+261
New +$203K 0.14% 94

Other funds holding LLY

Primoris Wealth Advisors's LLY Position: Q1 2026 in Review

Primoris Wealth Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 264 shares worth $243K. The position accounts for 0.17% of the portfolio, ranked #83.

Primoris Wealth Advisors first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $284K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Primoris Wealth Advisors held 264 shares of Eli Lilly worth $243K as of Q1 2026.
  • Primoris Wealth Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.17% of Primoris Wealth Advisors's portfolio in Q1 2026, its #83 holding.
  • Primoris Wealth Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Primoris Wealth Advisors's Eli Lilly position peaked at $284K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Primoris Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.